Clover Biopharmaceuticals - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeClover Biopharmaceuticals
Clover Biopharmaceuticals logo

Clover Biopharmaceuticals

0 followers

2197

Performance

About Clover Biopharmaceuticals

Clover Biopharmaceuticals is a global commercial-stage biopharmaceutical company focused on the discovery, development, and delivery of innovative vaccines to improve health worldwide. The company emphasizes its Trimer-Tag technology and in-house manufacturing capabilities to advance vaccine candidates and address infectious diseases. With global partnerships and a commitment to affordable solutions, Clover operates across international markets and clinical development programs. The organization is headquartered in a setting that highlights its global reach and leadership in vaccine science.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Team Members

Joshua Liang

Chief Executive Officer, Executive Director

Wei Tan, Ph.D.

Head of China Research

Peng Liang, Ph.D.

Founder, Chief Scientific Officer, Chairman of the Board

Nicolas Burdin, Ph.D.

Global Head of R&D

Key Facts

HQ Location

Cambridge, United States

Founded

2007

Employees

51 - 200

Status

Public

Website

https://cloverbiopharma.com